Pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Started the treatment for pulmonary metastasis before Dec. 31, 2020 in patients received radical resection (R0 or R1) for pancreatic cancer between Jan. 2009 and Dec. 2019. 2) Diagnosed as pancreatic ductal adenocarcinoma in reseced specimen. 3) Received chemotherapy or lung resection for only unilateral recurrent pulmonary metastasis .
Exclusion criteria
Exclusion criteria: 1) Intraductal papillary mucinous carcinoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | — |
Countries
Japan
Contacts
Osaka International Cancer Institute Department of Hepatobiliary and Pancreatic Oncology